Autonomic Dysfunction & Inflammation in Chronic Hemodialysis Patients

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02565459` - MSC and Kidney Transplant Tolerance (Phase A)	Phase 1
Recruiting	`NCT01876017` - Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure	Phase 1/Phase 2
Recruiting	`NCT02356419` - rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics	Phase 1
Withdrawn	`NCT03019159` - Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis	N/A
Completed	`NCT02047006` - Dose-finding of Rivaroxaban in Hemodialysis	Phase 4
Completed	`NCT01617824` - Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes	Phase 4
Completed	`NCT00828776` - Pharmacodynamics and Non-Clinical Inferiority of Heparin Sodium (Cristália) Compared With the Product Liquemine (Roche) in Chronic Renal Failure	Phase 2/Phase 3
Completed	`NCT00597753` - Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis	Phase 3
Terminated	`NCT00372489` - Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD	Phase 2
Completed	`NCT00379899` - ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis	Phase 4
Completed	`NCT00228436` - Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients	Phase 2
Completed	`NCT03772171` - Estimate for Dietary Intakes and Hemodialysis Patients
Recruiting	`NCT02586402` - Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis	Phase 2
Completed	`NCT01879618` - Use Of Fragmin In Hemodialysis	Phase 3
Not yet recruiting	`NCT01346215` - Study of Clinical Non-inferiority of Actparin® (Laboratorio Bergamo) Compared to Heparin Sodium (APP Pharmaceuticals), in Patients With Chronic Renal Failure	Phase 3
Completed	`NCT01220843` - FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease	Phase 3
Completed	`NCT01111630` - Study of Erythropoietin (EPO) Administration Schedule	Phase 4
Completed	`NCT00742716` - Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease	Phase 2
Completed	`NCT00597584` - Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis	Phase 3
Completed	`NCT00598273` - Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis	Phase 3

NCT number	NCT00878033
Study type	Observational
Source	Martin-Luther-Universität Halle-Wittenberg
Contact
Status	Completed
Phase	N/A
Start date	April 2009
Completion date	December 2010

Autonomic Dysfunction and Inflammation in Chronic Hemodialysis Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms